Canadian Marijuana Stock in Fresh Trouble

Should cannabis investors buy the dip on Namaste Technologies Inc (TSXV:N) stock as new problems surface?

| More on:
Road sign warning of a risk ahead

Image source: Getty Images.

You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn moresdf

Just when the marijuana stock seemed to have weathered a negative revenue-growth streak, discouraging news keeps coming out of Namaste Technologies (TSXV:N). The latest news release may make concerned investors decide to completely stay away from the cannabis retailer’s ticker for a longer while.

The company’s press statement of March 5 was loaded with some scary stuff.

Reputable auditor resigns

Namaste’s new auditor PricewaterhouseCoopers LLP (PwC) has resigned after just five months on the job! PwC was appointed auditor at Namaste in September last year after a previous auditor was fired by the company for no disclosed reason.

The company revealed that PwC “resigned on its own initiative” and the audit firm “did not complete an audit of the corporation since its appointment.”

While it is stated that PwC has nothing material to report concerning its voluntary resignation from the job, investors shouldn’t take auditor resignations lightly, especially one that happens when a newly appointed auditor could not complete its first-ever year-end audit and leaves right in the middle of it.

The reason for the resignation remains a subject of speculation. There could have been some conflict on the application of accounting rules and reporting standards or other grave issues, like financial mismanagement or worse, but until such issues surface later, investors may remain skeptical of the company’s financial performance and status of internal affairs.

Naturally, an accounting firm won’t typically resign from a lucrative client, unless if their priced reputation is at stake, or there is another very good reason. Whatever the reason, an auditor’s resignation may imply some severe problems in a listed company.

Potential failure to report

The company says that it may fail to file annual financial statements by the March 31, 2019, regulatory deadline.

The potential deadline miss may be related to the untimely departure of an auditor before the conclusion of financial audits for the fiscal year, and the company is in the process of finding a new auditor who will also take some time to go through the review process.

Whatever the reason for missing a filing deadline is, this is a bad incident that further damages a company’s reputation, or what’s left of it, after previous reports of insider self-dealing and breaches of fiduciary duty by the CEO concerning a sold U.S. subsidiary were confirmed by the company recently.

Legal counsel lapses?

After recent management changes, the company is thoroughly reviewing its businesses to ensure strategic focus and full compliance with local market laws in its global e-commerce businesses.

Compliance issues are material to the stock as any breaches may attract hefty fines and business activity bans. Such reviews are critical, and are usually done before business launches, after which continuous monitoring commences. Could there have been some lapses in the firm’s legal counsel?

Then some regulatory breach in Brazil…

Some irregular tobacco product adverts were reportedly flown on the company’s online store in Brazil, and the regulator there is about to take some action against the company. In response, Namaste has suspended its store’s operations while taking corrective action.

The Brazilian market contributed 8% to Namaste’s revenue for the 15 months to November 2018, and this market remains an important growth front to the company.

Generally, being on a national regulator’s bad side isn’t a good thing, and the situation could sometimes get worse in an emerging economy.

Foolish bottom line

Namaste is making a history of trouble, and the recent skirmishes with its former CEO Sean Dollinger are still fresh in the investor’s notebook. Although a settlement and cease-fire arrangement were entered with the founding CEO after internal investigations incriminated him, equity investors have suffered the brunt through a tanking share price.

Management’s focus on regulatory compliance and the ongoing strategic business review are welcome, but the exercises paint a hazy picture of the firm’s corporate governance controls and procedures.

Contrarian investors may be tempted to buy the dip on the stock, and there are potential massive recovery gains here, but I would urge caution. Untimely auditor resignations and frequent auditor changes are serious red flags that may signal a high-risk client and paint a gloomy earnings outlook.

Beware the magnified investment risk!

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Brian Paradza has no position in any of the stocks mentioned.

More on Cannabis Stocks

Cannabis smoke
Cannabis Stocks

Canopy Growth Stock: Is Now a Good Time to Invest?

The road ahead is highly uncertain for Canopy Growth, as the stock is plagued with losses and seemingly unsurmountable industry…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

TLRY Stock: Should You Invest Now?

TLRY is a Canadian cannabis stock which is trading 91% below record highs. Let's see if you should own TLRY…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Is Tilray Stock a Buy in February 2023?

Despite the volatile cannabis sector, Tilray could be a superb buy for long-term investors.

Read more »

Young woman sat at laptop by a window
Cannabis Stocks

Is SNDL Stock a Buy in February 2023?

SNDL is a beaten-down cannabis stock. While its revenue growth is exceptional, a weak balance sheet has driven stock prices…

Read more »

A cannabis plant grows.
Cannabis Stocks

TLRY Stock: Here’s What’s Coming in 2023

Tilray Inc. (TSX:TLRY) is geared up for big growth this decade and looks like one of the top cannabis stocks…

Read more »

A person holds a small glass jar of marijuana.
Cannabis Stocks

Canopy Growth Stock: Here’s What’s Coming in 2023

Canopy Growth stock has made a lot of new moves in the last few months, but where is the company…

Read more »

A cannabis plant grows.
Cannabis Stocks

Better Cannabis Buy: Canopy Growth Stock or Tilray?

Only two TSX weed stocks can deliver substantial returns in the highly anticipated growth of the global cannabis market.

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

Is Tilray Stock a Buy in January 2023?

Tilray stock has lost 50% of its value in the last 12 months, in line with its peers.

Read more »